Skip to content

Efficacy and Safety of Pegmolesatide, a Novel Treatment for Anemia in Patients with Chronic Kidney Disease

Anemia is a common complication in patients with chronic kidney disease (CKD), significantly lowering patients’ quality of life and increasing cardiovascular risks. Traditionally, recombinant erythropoietin (EPO), such as epoetin alfa, has been used to treat… Efficacy and Safety of Pegmolesatide, a Novel Treatment for Anemia in Patients with Chronic Kidney Disease